Telescope Innovations (CSE:TELI) CEO Prof Jason Hein joined Steve Darling from Proactive to share news about the company that looking to develop scalable manufacturing processes and tools for the pharmaceutical and chemical industry. That includes automation, contract research, and IP licensing. Hein telling Proactive the company has made major strides in its year of operation with the company announcing a 60% increase in Revenue from Q1 to Q2 in 2023 moving Telescope to the positive side of the ledger. The company is looking to scale up and increase its product sales. To do so, they plan to attend technical conferences and engage in media roadshows to showcase their technology and help clients improve their chemical manufacturing processes.
Telescope Innovations reports first profitable quarter with 60% increase in revenue from Q1
